Progressive Supranuclear Palsy Market size was valued at USD 1.5 Billion in 2024 and is projected to reach USD 2.8 Billion by 2033, exhibiting a CAGR of 7.6% from 2026 to 2033.
South Korea's Progressive Supranuclear Palsy (PSP) market is witnessing significant growth, driven by increased disease awareness and advancements in therapeutic research. The market is projected to experience a robust compound annual growth rate (CAGR) of 38.18% from 2024 to 2031, with the market size expected to reach USD 801.67 million by 2031.
Key factors contributing to this growth include:
Pharmacological Therapies: Dominating the treatment landscape, pharmacological interventions accounted for 18.39% of the market share in 2023. Levodopa remains a cornerstone in managing motor symptoms, while antidepressants address mood disturbances.
Application in Treatment: The treatment segment held the largest market share of 83.31% in 2023, emphasizing the focus on therapeutic interventions to improve patient quality of life.
End-User Industries: Hospitals are the primary end-users, representing 77.13% of the market in 2023. They play a crucial role in diagnosis, treatment, and ongoing management of PSP patients.
Despite the promising outlook, the market faces challenges such as limited understanding of disease pathophysiology and regulatory barriers. However, opportunities lie in novel therapeutic approaches and personalized treatment strategies.
In my experience, the integration of multidisciplinary care teams in hospitals has significantly improved patient outcomes. Collaborations between neurologists, physical therapists, and speech therapists have led to comprehensive care plans tailored to individual patient needs.
Furthermore, the rise of telemedicine has expanded access to specialized care, particularly in rural areas. Virtual consultations have become instrumental in providing continuous support to PSP patients, ensuring timely interventions and monitoring.
As the Progressive Supranuclear Palsy Market continues to evolve, stakeholders must focus on research and development, patient-centric care models, and policy frameworks that facilitate innovation and accessibility.
Get an In-Depth Research Analysis of the South Korea Progressive Supranuclear Palsy Market Size And Forecast [2025-2032]
Merck & Co.
Inc.
Aton Pharma
Inc.
Bristol Myers Squibb (BMS)
GlaxoSmithKline plc
Novartis AG
Teva Pharmaceutical Industries Ltd.
AB Science
AbbVie Inc.
AlzProtect SAS
Cortice Biosciences
Inc.
Acorda Therapeutics Inc.
Biogen Inc.
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Progressive Supranuclear Palsy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Progressive Supranuclear Palsy Market
Classic PSP
PSP-Parkinsonism
PSP-Corticobasal Syndrome
Progressive Supranuclear Palsy with Dementia
Clinical Diagnosis
Neuroimaging Diagnosis
Genetic Diagnosis
Pharmacological Treatment
Non-Pharmacological Treatment
Surgical Treatment
Dopaminergic Agents
Antidepressants
Anticholinergics
NMDA Receptor Antagonists
Hospitals
Clinics
Research Institutes
Homecare Settings
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Progressive Supranuclear Palsy Market Research Analysis
1. Introduction of the South Korea Progressive Supranuclear Palsy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Progressive Supranuclear Palsy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Progressive Supranuclear Palsy Market, By Type
6. South Korea Progressive Supranuclear Palsy Market, By Application
7. South Korea Progressive Supranuclear Palsy Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Progressive Supranuclear Palsy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/